Reading Hormones Through The Failing Kidney: Pitfalls in Endocrine Test Interpretation in Chronic Kidney Disease.
文献摘要
Chronic kidney disease (CKD) alters the clearance, protein binding, secretion and measurement of many hormones, so endocrine test results in patients with reduced kidney function often cannot be interpreted using conventional reference intervals. Misinterpretation can lead to unnecessary investigation and treatment or to missed endocrine disease. In this review, we adopt a test-centered approach to endocrine evaluation in adults with CKD stages G3-G5. We summarize how CKD affects glycemic markers, thyroid function tests, adrenal cortical and medullary tests, prolactin, the growth hormone-insulin-like growth factor 1 (IGF-1) axis, gonadal hormones and human chorionic gonadotropin (hCG), parathyroid hormone (PTH) and bone turnover markers, and calcitonin and chromogranin A. For each, we identify the dominant mechanism (reduced renal clearance, altered binding proteins, genuine axis dysregulation, analytical interference, or treatment effects) and the tests that remain reliable. Key recommendations include pairing glycated hemoglobin (HbA1c) with continuous glucose monitoring in advanced CKD, assessing thyroid function before dialysis and heparin, applying CKD stage-specific cut-offs to the dexamethasone suppression test, relying on renin suppression when screening for primary aldosteronism, avoiding urinary free cortisol and urinary metanephrines, interpreting PTH as a trend using a single assay, and using non-renally cleared bone turnover markers. We conclude with a practical approach that includes shared decision-making and research priorities for CKD-specific reference intervals.